Steris (NYSE: STE) reported Q1 EPS of $2.83, $0.02 worse than the analyst estimate of $2.85. Revenue for the quarter came in at $1.6 billion versus the consensus estimate of $1.59 billion.

GUIDANCE:

Steris sees FY2026 EPS of $11.10-$11.30, versus the consensus of $10.20.

For earnings history and earnings-related data on Steris (STE) click here.